Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) FCF Margin (2022 - 2023)

Historic FCF Margin for Lexeo Therapeutics (LXEO) over the last 1 years, with Q4 2023 value amounting to 28046.0%.

  • Lexeo Therapeutics' FCF Margin changed N/A to 28046.0% in Q4 2023 from the same period last year, while for Dec 2023 it was 29078.54%, marking a year-over-year change of. This contributed to the annual value of 59585.4% for FY2024, which is 305068600.0% up from last year.
  • As of Q4 2023, Lexeo Therapeutics' FCF Margin stood at 28046.0%.
  • In the past 5 years, Lexeo Therapeutics' FCF Margin ranged from a high of 36772.0% in Q1 2023 and a low of 24969.81% during Q2 2023